Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gut Microbiome Disruption Following SARS-CoV-2: A Review.
Righi E, Dalla Vecchia I, Auerbach N, Morra M, Górska A, Sciammarella C, Lambertenghi L, Gentilotti E, Mirandola M, Tacconelli E, Sartor A. Righi E, et al. Among authors: morra m. Microorganisms. 2024 Jan 9;12(1):131. doi: 10.3390/microorganisms12010131. Microorganisms. 2024. PMID: 38257958 Free PMC article. Review.
Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study.
Savoldi A, Morra M, Castelli A, Mirandola M, Berkell M, Smet M, Konnova A, Rossi E, Cataudella S, De Nardo P, Gentilotti E, Gupta A, Fasan D, Gibbin E, Cioli Puviani F, Hasenauer J, Gusinow R, Tami A, Kumar-Singh S, Malhotra-Kumar S, mAb Orchestra Working Group, Tacconelli E. Savoldi A, et al. Among authors: morra m. Biomedicines. 2022 Aug 24;10(9):2063. doi: 10.3390/biomedicines10092063. Biomedicines. 2022. PMID: 36140162 Free PMC article.
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern.
Mazzaferri F, Mirandola M, Savoldi A, De Nardo P, Morra M, Tebon M, Armellini M, De Luca G, Calandrino L, Sasset L, D'Elia D, Sozio E, Danese E, Gibellini D, Monne I, Scroccaro G, Magrini N, Cattelan A, Tascini C; MANTICO Working Group; Tacconelli E. Mazzaferri F, et al. Among authors: morra m. Elife. 2022 Nov 22;11:e79639. doi: 10.7554/eLife.79639. Elife. 2022. PMID: 36413383 Free PMC article. Clinical Trial.
Diagnostic Accuracy of a Rapid SARS-CoV-2 Antigen Test Among People Experiencing Homelessness: A Prospective Cohort and Implementation Study.
De Nardo P, Tebon M, Savoldi A, Soriolo N, Danese E, Peserico D, Morra M, Gentilotti E, Caliskan G, Marchetti P, Cecchetto R, Mazzariol A, Verlato G, Gibellini D, Tacconelli E. De Nardo P, et al. Among authors: morra m. Infect Dis Ther. 2023 Apr;12(4):1073-1082. doi: 10.1007/s40121-023-00787-0. Epub 2023 Mar 13. Infect Dis Ther. 2023. PMID: 36907951 Free PMC article.
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments.
Gupta A, Konnova A, Smet M, Berkell M, Savoldi A, Morra M, Van Averbeke V, De Winter FH, Peserico D, Danese E, Hotterbeekx A, Righi E; mAb ORCHESTRA working group; De Nardo P, Tacconelli E, Malhotra-Kumar S, Kumar-Singh S. Gupta A, et al. Among authors: morra m. J Clin Invest. 2023 Mar 15;133(6):e166032. doi: 10.1172/JCI166032. J Clin Invest. 2023. PMID: 36727404 Free PMC article.
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study.
Savoldi A, Morra M, De Nardo P, Cattelan AM, Mirandola M, Manfrin V, Scotton P, Giordani MT, Brollo L, Panese S, Lanzafame M, Scroccaro G, Berkell M, Lippi G, Konnova A, Smet M, Malhotra-Kumar S, Kumar-Singh S, Tacconelli E; mAb Working Group. Savoldi A, et al. Among authors: morra m. Eur J Clin Microbiol Infect Dis. 2022 Jul;41(7):1065-1076. doi: 10.1007/s10096-022-04464-x. Epub 2022 Jun 21. Eur J Clin Microbiol Infect Dis. 2022. PMID: 35727429 Free PMC article.
285 results